157 related articles for article (PubMed ID: 4091134)
1. [A clinical study of renal cell carcinoma].
Uchida T; Izumi H; Kobayashi K; Arakawa T; Honda N; Omata T; Odajima K; Mashimo S; Endo T; Ishibashi A
Hinyokika Kiyo; 1985 Nov; 31(11):1919-25. PubMed ID: 4091134
[TBL] [Abstract][Full Text] [Related]
2. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
3. [Outcome of patients in metastatic renal cell carcinoma with or without embolization].
Masuda F; Nakada J; Takasaka S; Hishinuma H
Hinyokika Kiyo; 1987 Sep; 33(9):1354-6. PubMed ID: 3434491
[TBL] [Abstract][Full Text] [Related]
4. Preoperative renal tumor embolization. A useful procedure?
Fischedick AR; Peters PE; Kleinhans G; Pfeifer E
Acta Radiol; 1987; 28(3):303-6. PubMed ID: 2958037
[TBL] [Abstract][Full Text] [Related]
5. [Influential clinical and pathological factors on prognosis of renal cell carcinoma].
Saika T; Yamamoto Y; Takeda K; Asahi T
Hinyokika Kiyo; 1994 Mar; 40(3):189-93. PubMed ID: 7513936
[TBL] [Abstract][Full Text] [Related]
6. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study on renal cell carcinoma].
Yanagawa M; Suzuki S; Kameda K; Nakano S; Kinbara H; Araki T; Sakurai M; Hioki T; Sugimura Y; Tochigi H
Hinyokika Kiyo; 1991 Oct; 37(10):1215-21. PubMed ID: 1755414
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
9. [Improvement in the prognosis of renal cell carcinoma by percutaneous transvascular embolization].
Stösslein F; Schwenke A; Münster W; Köhler H; Mebel M; Raatzsch H; Steude U; Krosegk G
Z Urol Nephrol; 1987 Oct; 80(10):577-86. PubMed ID: 3433986
[TBL] [Abstract][Full Text] [Related]
10. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
11. [Recent management of renal cell carcinoma].
Nishio Y; Yoshida O
Gan To Kagaku Ryoho; 1988 Feb; 15(2):219-23. PubMed ID: 3257677
[TBL] [Abstract][Full Text] [Related]
12. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
13. [Definition of early renal cell carcinoma--from the study of pathological and clinical findings according to tumor size].
Kitamura Y; Watanabe M; Komatubara S; Sakata Y
Hinyokika Kiyo; 1995 Jul; 41(7):511-5. PubMed ID: 7668180
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
[TBL] [Abstract][Full Text] [Related]
15. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
16. [Long-term results of endovascular treatment of metastatic renal cell cancer].
Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the patients with renal cell carcinoma before and after 1980].
Onishi T; Machida T; Masuda F; Suzuki M; Furuta N
Hinyokika Kiyo; 1990 Aug; 36(8):879-85. PubMed ID: 2239588
[TBL] [Abstract][Full Text] [Related]
18. [Effect of kidney occlusion on survival in renal cell carcinoma: a 10-year retrospective study].
Latal D; Kautzky W; Wanek R; Kumpan W
Z Urol Nephrol; 1990 Jan; 83(1):27-31. PubMed ID: 2330762
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
[TBL] [Abstract][Full Text] [Related]
20. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
